Major trial seeks to test semaglutide on adults with alcohol and opioid use disorder
The Center for Addiction Science, Policy and Research (CASPR) and the Allegheny County Department of Human Services are preparing to launch a major $13.3 million randomized controlled trial to test whether weekly semaglutide, as an additional support to existing care, can reduce alcohol and opioid use and reduce criminal-justice involvement while improving employment, health, and housing outcomes…
Read original article on The Medical News →Related news
-
Scientists find strange bacterial immune system that works backward
United Kingdom
-
Early axial spondyloarthritis diagnosis linked to lower long-term spinal damage
United Kingdom
-
Prime editing repairs immune disorder defect in patient's own blood stem cells
United Kingdom
-
Hybrid AI architecture improves seizure prediction using EEG signals
United Kingdom
-
Drug tapering noninferior to treatment continuation for rheumatoid arthritis with low disease activity
United Kingdom
-
Toddler EEG study shows why story time and playtime really matter
United Kingdom
-
ACLM launches resources to meet new medical nutrition requirements
United Kingdom
-
Topical peptide spray outperforms placebo in healing burn wounds
United Kingdom